Voting Rights Announcements | 21 May 2013 16:26


STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

21.05.2013 16:26

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------




1. Threadneedle Asset Management Holdings Limited

Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG on 21 May 2013, that on 16 May 2013 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.00% (587,127 voting rights).
Threadneedle Asset Management Holdings Limited has notified us that these
voting rights of 5.00% (587,127 voting rights) are attributable to
Threadneedle Asset Management Holdings Limited pursuant to sec. 22 para. 1
sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management Holdings
Limited inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.



2. Threadneedle Asset Management Limited

Threadneedle Asset Management Limited, London, UK, has notified us pursuant
to sec. 21 para. 1 WpHG on 21 May 2013, that on 16 May 2013 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.00% (587,127 voting rights).
Threadneedle Asset Management Limited has notified us that these voting
rights of 5.00% (587,127 voting rights) are attributable to Threadneedle
Asset Management Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.

The voting rights were attributed to Threadneedle Asset Management Limited
inter alia from Threadneedle Investment Funds ICVC, being a shareholder
holding 3% or more of the voting rights in STRATEC Biomedical AG.



21.05.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------